Nexvet Biopharma plc (a Nasdaq-listed bio-pharmaceutical company) was advised by Matheson on its $85 million public takeover by Zoetis (the global leading animal health company with revenues of $4.9 billion), by way of scheme of arrangement under the Irish Companies Act and pursuant to the Irish Takeover Rules.
